Edgewise Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | +50.4% | +47.0% | +97.8% | +221.9% | +32.2% | -1.0% | |
| – | +359.7% | +1,144.1% | +148.0% | +60.7% | +40.7% | +40.6% | |
| – | +359.7% | +1,144.1% | +148.0% | – | – | – | |
| – | +483.8% | +137.4% | -11.7% | -138.2% | – | -152.0% | |
| – | +12.8% | +229.1% | +730.2% | +3.6% | -77.2% | -80.5% | |
| – | +13,445.0% | +893.5% | -70.9% | – | -279.5% | -82.2% | |
| – | – | – | -30.3% | – | – | – | |
| – | – | – | – | – | – | – | |
| – | +385.0% | +55.0% | -30.4% | -59.0% | +368.8% | -21.3% | |
| – | +426.0% | -210.0% | – | +897.4% | -169.3% | – | |
| – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.